These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 19014931

  • 1. CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats.
    Yoshida T, Okuno A, Izumi M, Takahashi K, Hagisawa Y, Ohsumi J, Fujiwara T.
    Eur J Pharmacol; 2008 Dec 28; 601(1-3):192-7. PubMed ID: 19014931
    [Abstract] [Full Text] [Related]

  • 2. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
    Yoshida T, Okuno A, Tanaka J, Takahashi K, Nakashima R, Kanda S, Ogawa J, Hagisawa Y, Fujiwara T.
    Eur J Pharmacol; 2009 Nov 25; 623(1-3):141-7. PubMed ID: 19765581
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
    van Poelje PD, Potter SC, Chandramouli VC, Landau BR, Dang Q, Erion MD.
    Diabetes; 2006 Jun 25; 55(6):1747-54. PubMed ID: 16731838
    [Abstract] [Full Text] [Related]

  • 4. Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.
    van Poelje PD, Potter SC, Erion MD.
    Handb Exp Pharmacol; 2011 Jun 25; (203):279-301. PubMed ID: 21484576
    [Abstract] [Full Text] [Related]

  • 5. Contributions of hepatic gluconeogenesis suppression and compensative glycogenolysis on the glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, in non-obese type 2 diabetes Goto-Kakizaki rats.
    Yoshida T, Okuno A, Takahashi K, Ogawa J, Hagisawa Y, Kanda S, Fujiwara T.
    J Pharmacol Sci; 2011 Jun 25; 115(3):329-35. PubMed ID: 21350313
    [Abstract] [Full Text] [Related]

  • 6. MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes.
    Erion MD, van Poelje PD, Dang Q, Kasibhatla SR, Potter SC, Reddy MR, Reddy KR, Jiang T, Lipscomb WN.
    Proc Natl Acad Sci U S A; 2005 May 31; 102(22):7970-5. PubMed ID: 15911772
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
    Ueta K, Ishihara T, Matsumoto Y, Oku A, Nawano M, Fujita T, Saito A, Arakawa K.
    Life Sci; 2005 Apr 22; 76(23):2655-68. PubMed ID: 15792833
    [Abstract] [Full Text] [Related]

  • 8. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.
    Azuma K, Toyofuku Y, Iesaki T, Otsuka A, Tanaka A, Mita T, Hirose T, Tanaka Y, Daida H, Kawamori R, Watada H.
    Biochem Biophys Res Commun; 2006 Jun 30; 345(2):688-93. PubMed ID: 16696939
    [Abstract] [Full Text] [Related]

  • 9. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
    Dang Q, Kasibhatla SR, Reddy KR, Jiang T, Reddy MR, Potter SC, Fujitaki JM, van Poelje PD, Huang J, Lipscomb WN, Erion MD.
    J Am Chem Soc; 2007 Dec 19; 129(50):15491-502. PubMed ID: 18041834
    [Abstract] [Full Text] [Related]

  • 10. [Recent advance in the discovery of allosteric inhibitors binding to the AMP site of fructose-1,6-bisphosphatase].
    Li ZM, Bie JB, Song HR, Xu BL.
    Yao Xue Xue Bao; 2011 Nov 19; 46(11):1291-300. PubMed ID: 22260018
    [Abstract] [Full Text] [Related]

  • 11. Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats.
    Goda T, Suruga K, Komori A, Kuranuki S, Mochizuki K, Makita Y, Kumazawa T.
    Br J Nutr; 2007 Oct 19; 98(4):702-10. PubMed ID: 17537288
    [Abstract] [Full Text] [Related]

  • 12. Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats.
    Li Y, Wen S, Kota BP, Peng G, Li GQ, Yamahara J, Roufogalis BD.
    J Ethnopharmacol; 2005 Jun 03; 99(2):239-44. PubMed ID: 15894133
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased secretion and expression of amylin in spontaneously diabetic Goto-Kakizaki rats treated with rhGLP-1 (7-36).
    Weng HB, Gu Q, Liu M, Cheng NN, Li D, Gao X.
    Acta Pharmacol Sin; 2008 May 03; 29(5):573-9. PubMed ID: 18430365
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Improvement in glucose tolerance as a result of enhanced insulin sensitivity during electroacupuncture in spontaneously diabetic Goto-Kakizaki rats.
    Ishizaki N, Okushi N, Yano T, Yamamura Y.
    Metabolism; 2009 Oct 03; 58(10):1372-8. PubMed ID: 19501858
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.